ACTEMRA

ACTEMRA

tocilizumab

Manufacturer:

Roche
Basic Prescribing Info
Contents
tocilizumab.
CIMS Class
Disease-Modifying Anti-Rheumatic Drugs (DMARDs) / Immunosuppressants
ATC Classification
L04AC07 - tocilizumab ; Belongs to the class of interleukin inhibitors. Used as immunosuppressants.
Presentation/Packing
Form
ACTEMRA inj
Packing/Price
20 mg x 1 mL x 10ml (20,436.19 INR);20 mg x 1 mL x 20ml (40,600 INR);20 mg x 1 mL x 4ml (8,112 INR);162 mg x 1 (22,064 INR)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in